Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GenVec has received a Small Business Innovation and Research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to support the company's malaria vaccine program.
Subscribe to our email newsletter
This grant, valued at approximately $600,000 over two years, will be used to develop enhancements to the company’s vectors for vaccine applications against malaria.
Rick King, GenVec’s senior vice president of research, said: “In addition to advancing our malaria vaccine program, work under this grant may provide improvements to our technology that could be applied to other adenovector-based vaccines and therapeutics.”